Unsealed court documents reveal a whistleblower suit over UnitedHealth use of an artery disease test
Whistleblowers are suing UnitedHealth Group over its use of a peripheral artery disease test, called QuantaFlo, to increase ...
Semler Scientific's core healthcare business faces revenue declines and regulatory risks. Click here to read an analysis of ...
Semler Scientific has offered to pay the Department of Justice nearly $30 million to settle federal healthcare fraud claims related to its peripheral artery disease test, QuantaFlo — a product used by ...
CEO Doug Murphy-Chutorian highlighted strong performance and cash generation from healthcare operations in 2024. He emphasized the company's focus on its Bitcoin treasury strategy, with Bitcoin now ...
Semler Scientific Inc. (NASDAQ:SMLR) is one of the best cryptocurrency stocks to buy according to Wall Street Analysts. On September 16, the company entered into a settlement agreement with the ...
Semler Scientific Inc. advanced stock charts by Barron's. View SMLR historical stock data and compare to other stocks, and exchanges.
Semler Scientific will pay the Department of Justice nearly $30 million to settle health care fraud claims related to its peripheral artery disease test, QuantaFlo — a device used by UnitedHealth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results